Despite modern pharmacotherapy and advanced implantable cardiac devices, overall prognosis and quality of life of HF patients remain poor. This is in part due to insufficient patient stratification and lack of individualized therapy planning, resulting in less effective treatments and a significant number of non-responders.State-of-the-art clinical phenotyping was acquired, including magnetic resonance imaging (MRI) and biomarker assessment. An individualized, multi-scale model of heart function covering cardiac anatomy, electrophysiology, biomechanics and hemodynamics was estimated using a robust framework. The model was computed on n=46 HF patients, showing for the first time that advanced multi-scale models can be fitted consistently on ...
International audienceCardiovascular diseases (CVD) are the major cause of morbidity and mortality i...
Introduction From a prospective multicentre multicountry clinical trial, we developed and validated ...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Despite modern pharmacotherapy and advanced implantable cardiac devices, overall prognosis and quali...
<div><p>Background</p><p>Despite modern pharmacotherapy and advanced implantable cardiac devices, ov...
International audienceThe loss of cardiac pump function accounts for a significant increase in both ...
Cardiovascular diseases (CVDs) are the leading cause of death in the western world. With the current...
Heart failure (HF) is a complex syndrome which can be the exit of different etiologies which lead to...
A model-based approach was developed to elucidate etiological differences between and within patient...
Computational models are an absolutely necessary tool in many engineering disciplines. For example, ...
Heart failure (HF) is a chronic clinical condition in which the heart fails to pump enough blood to ...
Many cardiac diseases lead to heart failure (HF) causing increasing morbidity and mortality worldwid...
Cardiac resynchronization therapy (CRT) is an effective treatment for heart failure (HF) patients wi...
Patient-specific models of single ventricle circulation represent a powerful tool to investigate ven...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
International audienceCardiovascular diseases (CVD) are the major cause of morbidity and mortality i...
Introduction From a prospective multicentre multicountry clinical trial, we developed and validated ...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Despite modern pharmacotherapy and advanced implantable cardiac devices, overall prognosis and quali...
<div><p>Background</p><p>Despite modern pharmacotherapy and advanced implantable cardiac devices, ov...
International audienceThe loss of cardiac pump function accounts for a significant increase in both ...
Cardiovascular diseases (CVDs) are the leading cause of death in the western world. With the current...
Heart failure (HF) is a complex syndrome which can be the exit of different etiologies which lead to...
A model-based approach was developed to elucidate etiological differences between and within patient...
Computational models are an absolutely necessary tool in many engineering disciplines. For example, ...
Heart failure (HF) is a chronic clinical condition in which the heart fails to pump enough blood to ...
Many cardiac diseases lead to heart failure (HF) causing increasing morbidity and mortality worldwid...
Cardiac resynchronization therapy (CRT) is an effective treatment for heart failure (HF) patients wi...
Patient-specific models of single ventricle circulation represent a powerful tool to investigate ven...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
International audienceCardiovascular diseases (CVD) are the major cause of morbidity and mortality i...
Introduction From a prospective multicentre multicountry clinical trial, we developed and validated ...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...